Key points are not available for this paper at this time.
In patients with refractory colorectal cancer, TAS-102, as compared with placebo, was associated with a significant improvement in overall survival. (Funded by Taiho Oncology-Taiho Pharmaceutical; RECOURSE ClinicalTrials.gov number, NCT01607957.).
Building similarity graph...
Analyzing shared references across papers
Loading...
Mayer et al. (Wed,) studied this question.
www.synapsesocial.com/papers/69daab49a6045d71bfa3db31 — DOI: https://doi.org/10.1056/nejmoa1414325
Robert J. Mayer
Eric Van Cutsem
Alfredo Falcone
New England Journal of Medicine
Harvard University
University of Southern California
Dana-Farber Cancer Institute
Building similarity graph...
Analyzing shared references across papers
Loading...